Interventional Radiology Products Market Size to Hit Around US$16.1 Billion by 2027
The global Interventional Radiology Products market gathered revenue around USD 9.0 Billion in 2020 and market is set to grow USD 16.1 Billion by the end of 2027 and is estimated to expand at a modest CAGR of 7.2% during the prediction period 2021 to 2027. The growth in this market can be attributed to the rising prevalence of chronic diseases, growing geriatric population, increasing demand for minimally invasive procedures, and favorable reimbursement scenario for interventional radiology procedures. Emerging markets in Asian countries are expected to offer strong growth opportunities for players in the market. In contrast, high cost and inaccessibility of advanced therapeutics may restrict market growth to a certain extent. The interventional radiology products market is segmented based on type, procedure, application, and region.
This research report purposes at stressing the most lucrative growth prospects. The aim of the research report is to provide an inclusive valuation of the Interventional Radiology Products market and it encompasses thoughtful visions, actualities, industry-validated market findings, historic data, and prognoses by means of appropriate set of assumptions and practice. Global Interventional Radiology Products market report aids in comprehending market structure and dynamics by recognizing and scrutinizing the market sectors and predicted the global market outlook.
COVID-19 Impact Assessment on Market Landscape
The report comprises the scrutiny of COVID-19 lock-down impact on the income of market leaders, disrupters and followers. Since lock down was instigated differently in diverse regions and nations, influence of same is also dissimilar across various industry verticals. The research report offers present short-term and long-term influence on the market to assist market participants across value chain makers to formulate the framework for short term and long-lasting tactics for recovery and by region.
Interventional Radiology Products market report empower readers with all-inclusive market intelligence and offers a granular outline of the market they are operational in. Further this research study delivers exceptional combination of tangible perceptions and qualitative scrutiny to aid companies accomplishes sustainable growth. This report employs industry-leading research practices and tools to assemble all-inclusive market studies, intermingled with pertinent data. Additionally, this report also emphases on the competitive examination of crucial players by analyzing their product portfolio, pricing, gross margins, financial position, growth approaches, and regional occurrence.
North America was the largest regional market for interventional radiology products market in 2020.
The interventional radiology products is segmented into North America, Europe, the Asia Pacific, and the Rest of the World. In 2020, North America was the largest regional segment of the overall market, followed by Europe. The large share of the North American market can be attributed to the high prevalence of chronic diseases, growing geriatric population, increasing adoption of minimally invasive procedures, and the presence of key players in the region.
Competitive Rivalry
Foremost players in the market are attentive on adopting corporation strategies to enhance their market share. Some of the prominent tactics undertaken by leading market participants in order to sustain the fierce market completion include collaborations, acquisitions, substantial spending in R&D and the improvement of new-fangled products or reforms among others.
Significant Market Participants Operational in the Interventional Radiology Products Market are:
Medtronic (Ireland), Boston Scientific Corporation (US), Becton, Dickinson and Company (US), Abbott (US), Cardinal Health (US), B. Braun Melsungen AG (Germany), Stryker (US), Terumo Medical Corporation (Japan), Cook Medical (US), Biosensors International Group, Ltd. (Singapore), Teleflex Incorporated (US), iVascular S.L.U. (Spain), Penumbra, Inc. (US), BIOTRONIK SE & Co. KG (Germany), ENDOCOR GmbH (Germany), Meril Life Sciences Pvt. Ltd. (India), Palex Medical (Spain), UreSil, LLC (US), Alvimedica (Turkey), Cardionovum GmbH (Germany), SMT (India), Medinol Ltd. (Israel), Comed B.V. (Netherlands), SCITECH (Brazil), Balton Sp. z o.o. (Poland), and Rontis (Switzerland).
Unravelling the Critical Segments
This research report offers market revenue, sales volume, production assessment and prognoses by classifying it on the basis of various aspects including product type, application/end-user, and region. Further, this research study investigates market size, production, consumption and its development trends at global, regional, and country level for period 2017 to 2027 and covers subsequent region in its scope:
By Type
By Procedure
By Application
By Geography
North America
Europe
Asia Pacific
Latin America
Middle East & Africa (MEA)
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. Market Dynamics Analysis and Trends
5.1. Market Dynamics
5.1.1. Market Drivers
5.1.2. Market Restraints
5.1.3. Market Opportunities
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining power of suppliers
5.2.2. Bargaining power of buyers
5.2.3. Threat of substitute
5.2.4. Threat of new entrants
5.2.5. Degree of competition
Chapter 6. Competitive Landscape
6.1.1. Company Market Share/Positioning Analysis
6.1.2. Key Strategies Adopted by Players
6.1.3. Vendor Landscape
6.1.3.1. List of Suppliers
6.1.3.2. List of Buyers
Chapter 7. Global Interventional Radiology Products Market, By Type
7.1. Interventional Radiology Products Market, By Type, 2021-2027
7.1.1. Catheters
7.1.1.1. Market Revenue and Forecast (2016-2027)
7.1.2. Stents
7.1.2.1. Market Revenue and Forecast (2016-2027)
7.1.3. Inferior Vena Cava (IVC) Filters
7.1.3.1. Market Revenue and Forecast (2016-2027)
7.1.4. Hemodynamic Flow Alteration Devices
7.1.4.1. Market Revenue and Forecast (2016-2027)
7.1.5. Angioplasty Balloons
7.1.5.1. Market Revenue and Forecast (2016-2027)
7.1.6. Thrombectomy Systems
7.1.6.1. Market Revenue and Forecast (2016-2027)
7.1.7. Embolization Devices
7.1.7.1. Market Revenue and Forecast (2016-2027)
7.1.8. Biopsy Needles
7.1.8.1. Market Revenue and Forecast (2016-2027)
7.1.9. Accessories
7.1.9.1. Market Revenue and Forecast (2016-2027)
7.1.10. Other Interventional Radiology Products
7.1.10.1. Market Revenue and Forecast (2016-2027)
Chapter 8. Global Interventional Radiology Products Market, By Procedure
8.1. Interventional Radiology Products Market, By Procedure, 2021-2027
8.1.1. Angioplasty
8.1.1.1. Market Revenue and Forecast (2016-2027)
8.1.2. Angioplasty
8.1.2.1. Market Revenue and Forecast (2016-2027)
8.1.3. Embolization
8.1.3.1. Market Revenue and Forecast (2016-2027)
8.1.4. Thrombolysis
8.1.4.1. Market Revenue and Forecast (2016-2027)
8.1.5. Biopsy & Drainage
8.1.5.1. Market Revenue and Forecast (2016-2027)
8.1.6. Vertebroplasty
8.1.6.1. Market Revenue and Forecast (2016-2027)
8.1.7. Nephrostomy
8.1.7.1. Market Revenue and Forecast (2016-2027)
8.1.8. Other Procedures
8.1.8.1. Market Revenue and Forecast (2016-2027)
Chapter 9. Global Interventional Radiology Products Market, By End User
9.1. Interventional Radiology Products Market, By End User, 2021-2027
9.1.1. Other Procedures
9.1.1.1. Market Revenue and Forecast (2016-2027)
9.1.2. Urology & Nephrology
9.1.2.1. Market Revenue and Forecast (2016-2027)
9.1.3. Urology & Nephrology
9.1.3.1. Market Revenue and Forecast (2016-2027)
9.1.4. Gastroenterology
9.1.4.1. Market Revenue and Forecast (2016-2027)
9.1.5. Neurology
9.1.5.1. Market Revenue and Forecast (2016-2027)
9.1.6. Neurology
9.1.6.1. Market Revenue and Forecast (2016-2027)
9.1.7. Other Applications
9.1.7.1. Market Revenue and Forecast (2016-2027)
Chapter 10.Global Interventional Radiology Products Market, Regional Estimates and Trend Forecast
10.1. North America
10.1.1. Market Revenue and Forecast, By Type (2016-2027)
10.1.2. Market Revenue and Forecast, By Procedure (2016-2027)
10.1.3. Market Revenue and Forecast, By End User (2016-2027)
10.1.4. U.S.
10.1.4.1. Market Revenue and Forecast, By Type (2016-2027)
10.1.4.2. Market Revenue and Forecast, By Procedure (2016-2027)
10.1.4.3. Market Revenue and Forecast, By End User (2016-2027)
10.1.5. Rest of North America
10.1.5.1. Market Revenue and Forecast, By Type (2016-2027)
10.1.5.2. Market Revenue and Forecast, By Procedure (2016-2027)
10.1.5.3. Market Revenue and Forecast, By End User (2016-2027)
10.2. Europe
10.2.1. Market Revenue and Forecast, By Type (2016-2027)
10.2.2. Market Revenue and Forecast, By Procedure (2016-2027)
10.2.3. Market Revenue and Forecast, By End User (2016-2027)
10.2.4. UK
10.2.4.1. Market Revenue and Forecast, By Type (2016-2027)
10.2.4.2. Market Revenue and Forecast, By Procedure (2016-2027)
10.2.4.3. Market Revenue and Forecast, By End User (2016-2027)
10.2.5. Germany
10.2.5.1. Market Revenue and Forecast, By Type (2016-2027)
10.2.5.2. Market Revenue and Forecast, By Procedure (2016-2027)
10.2.5.3. Market Revenue and Forecast, By End User (2016-2027)
10.2.6. France
10.2.6.1. Market Revenue and Forecast, By Type (2016-2027)
10.2.6.2. Market Revenue and Forecast, By Procedure (2016-2027)
10.2.6.3. Market Revenue and Forecast, By End User (2016-2027)
10.2.7. Rest of Europe
10.2.7.1. Market Revenue and Forecast, By Type (2016-2027)
10.2.7.2. Market Revenue and Forecast, By Procedure (2016-2027)
10.2.7.3. Market Revenue and Forecast, By End User (2016-2027)
10.3. APAC
10.3.1. Market Revenue and Forecast, By Type (2016-2027)
10.3.2. Market Revenue and Forecast, By Procedure (2016-2027)
10.3.3. Market Revenue and Forecast, By End User (2016-2027)
10.3.4. India
10.3.4.1. Market Revenue and Forecast, By Type (2016-2027)
10.3.4.2. Market Revenue and Forecast, By Procedure (2016-2027)
10.3.4.3. Market Revenue and Forecast, By End User (2016-2027)
10.3.5. China
10.3.5.1. Market Revenue and Forecast, By Type (2016-2027)
10.3.5.2. Market Revenue and Forecast, By Procedure (2016-2027)
10.3.5.3. Market Revenue and Forecast, By End User (2016-2027)
10.3.6. Japan
10.3.6.1. Market Revenue and Forecast, By Type (2016-2027)
10.3.6.2. Market Revenue and Forecast, By Procedure (2016-2027)
10.3.6.3. Market Revenue and Forecast, By End User (2016-2027)
10.3.7. Rest of APAC
10.3.7.1. Market Revenue and Forecast, By Type (2016-2027)
10.3.7.2. Market Revenue and Forecast, By Procedure (2016-2027)
10.3.7.3. Market Revenue and Forecast, By End User (2016-2027)
10.4. MEA
10.4.1. Market Revenue and Forecast, By Type (2016-2027)
10.4.2. Market Revenue and Forecast, By Procedure (2016-2027)
10.4.3. Market Revenue and Forecast, By End User (2016-2027)
10.4.4. GCC
10.4.4.1. Market Revenue and Forecast, By Type (2016-2027)
10.4.4.2. Market Revenue and Forecast, By Procedure (2016-2027)
10.4.4.3. Market Revenue and Forecast, By End User (2016-2027)
10.4.5. North Africa
10.4.5.1. Market Revenue and Forecast, By Type (2016-2027)
10.4.5.2. Market Revenue and Forecast, By Procedure (2016-2027)
10.4.5.3. Market Revenue and Forecast, By End User (2016-2027)
10.4.6. South Africa
10.4.6.1. Market Revenue and Forecast, By Type (2016-2027)
10.4.6.2. Market Revenue and Forecast, By Procedure (2016-2027)
10.4.6.3. Market Revenue and Forecast, By End User (2016-2027)
10.4.7. Rest of MEA
10.4.7.1. Market Revenue and Forecast, By Type (2016-2027)
10.4.7.2. Market Revenue and Forecast, By Procedure (2016-2027)
10.4.7.3. Market Revenue and Forecast, By End User (2016-2027)
10.5. Latin America
10.5.1. Market Revenue and Forecast, By Type (2016-2027)
10.5.2. Market Revenue and Forecast, By Procedure (2016-2027)
10.5.3. Market Revenue and Forecast, By End User (2016-2027)
10.5.4. Brazil
10.5.4.1. Market Revenue and Forecast, By Type (2016-2027)
10.5.4.2. Market Revenue and Forecast, By Procedure (2016-2027)
10.5.4.3. Market Revenue and Forecast, By End User (2016-2027)
10.5.5. Rest of LATAM
10.5.5.1. Market Revenue and Forecast, By Type (2016-2027)
10.5.5.2. Market Revenue and Forecast, By Procedure (2016-2027)
10.5.5.3. Market Revenue and Forecast, By End User (2016-2027)
Chapter 11. Company Profiles
11.1. Medtronic (Ireland)
11.1.1. Company Overview
11.1.2. Product Offerings
11.1.3. Financial Performance
11.1.4. Recent Initiatives
11.2. Boston Scientific Corporation (US)
11.2.1. Company Overview
11.2.2. Product Offerings
11.2.3. Financial Performance
11.2.4. Recent Initiatives
11.3. Becton, Dickinson and Company (US)
11.3.1. Company Overview
11.3.2. Product Offerings
11.3.3. Financial Performance
11.3.4. Recent Initiatives
11.4. Abbott (US)
11.4.1. Company Overview
11.4.2. Product Offerings
11.4.3. Financial Performance
11.4.4. Recent Initiatives
11.5. Cardinal Health (US)
11.5.1. Company Overview
11.5.2. Product Offerings
11.5.3. Financial Performance
11.5.4. Recent Initiatives
11.6. B. Braun Melsungen AG (Germany)
11.6.1. Company Overview
11.6.2. Product Offerings
11.6.3. Financial Performance
11.6.4. Recent Initiatives
11.7. Stryker (US)
11.7.1. Company Overview
11.7.2. Product Offerings
11.7.3. Financial Performance
11.7.4. Recent Initiatives
11.8. Terumo Medical Corporation (Japan)
11.8.1. Company Overview
11.8.2. Product Offerings
11.8.3. Financial Performance
11.8.4. Recent Initiatives
11.9. Cook Medical (US)
11.9.1. Company Overview
11.9.2. Product Offerings
11.9.3. Financial Performance
11.9.4. Recent Initiatives
11.10. Biosensors International Group, Ltd. (Singapore)
11.10.1. Company Overview
11.10.2. Product Offerings
11.10.3. Financial Performance
11.10.4. Recent Initiatives
11.11. Teleflex Incorporated (US)
11.11.1. Company Overview
11.11.2. Product Offerings
11.11.3. Financial Performance
11.11.4. Recent Initiatives
11.12. iVascular S.L.U. (Spain)
11.12.1. Company Overview
11.12.2. Product Offerings
11.12.3. Financial Performance
11.12.4. Recent Initiatives
11.13. Penumbra, Inc. (US)
11.13.1. Company Overview
11.13.2. Product Offerings
11.13.3. Financial Performance
11.13.4. Recent Initiatives
11.14. BIOTRONIK SE & Co. KG (Germany)
11.14.1. Company Overview
11.14.2. Product Offerings
11.14.3. Financial Performance
11.14.4. Recent Initiatives
11.15. ENDOCOR GmbH (Germany)
11.15.1. Company Overview
11.15.2. Product Offerings
11.15.3. Financial Performance
11.15.4. Recent Initiatives
11.16. Meril Life Sciences Pvt. Ltd. (India)
11.16.1. Company Overview
11.16.2. Product Offerings
11.16.3. Financial Performance
11.16.4. Recent Initiatives
11.17. Palex Medical (Spain)
11.17.1. Company Overview
11.17.2. Product Offerings
11.17.3. Financial Performance
11.17.4. Recent Initiatives
11.18. UreSil, LLC (US)
11.18.1. Company Overview
11.18.2. Product Offerings
11.18.3. Financial Performance
11.18.4. Recent Initiatives
11.19. Alvimedica (Turkey)
11.19.1. Company Overview
11.19.2. Product Offerings
11.19.3. Financial Performance
11.19.4. Recent Initiatives
11.20. Cardionovum GmbH (Germany)
11.20.1. Company Overview
11.20.2. Product Offerings
11.20.3. Financial Performance
11.20.4. Recent Initiatives
11.21. SMT (India)
11.21.1. Company Overview
11.21.2. Product Offerings
11.21.3. Financial Performance
11.21.4. Recent Initiatives
11.22. Medinol Ltd. (Israel)
11.22.1. Company Overview
11.22.2. Product Offerings
11.22.3. Financial Performance
11.22.4. Recent Initiatives
11.23. Comed B.V. (Netherlands)
11.23.1. Company Overview
11.23.2. Product Offerings
11.23.3. Financial Performance
11.23.4. Recent Initiatives
11.24. SCITECH (Brazil)
11.24.1. Company Overview
11.24.2. Product Offerings
11.24.3. Financial Performance
11.24.4. Recent Initiatives
11.25. Balton Sp. z o.o. (Poland)
11.25.1. Company Overview
11.25.2. Product Offerings
11.25.3. Financial Performance
11.25.4. Recent Initiatives
11.26. Rontis (Switzerland)
11.26.1. Company Overview
11.26.2. Product Offerings
11.26.3. Financial Performance
11.26.4. Recent Initiatives
Chapter 12. Research Methodology
12.1. Primary Research
12.2. Secondary Research
12.3. Assumptions
Chapter 13. Appendix
13.1. About Us
13.2. Glossary of Terms
Cross-segment Market Size and Analysis for
Mentioned Segments
Additional Company Profiles (Upto 5 With No Cost)
Additional Countries (Apart From Mentioned Countries)
Country/Region-specific Report
Go To Market Strategy
Region Specific Market DynamicsRegion Level Market Share Import Export AnalysisProduction AnalysisOthers